uniQure
QURE
#5106
Rank
C$2.34 B
Marketcap
C$37.19
Share price
-2.52%
Change (1 day)
94.56%
Change (1 year)

Revenue for uniQure (QURE)

Revenue in 2026 (TTM): C$24.88 Million

According to uniQure's latest financial reports the company's current revenue (TTM ) is C$24.87 Million. In 2025 the company made a revenue of C$22.04 Million a decrease over the revenue in the year 2024 that were of C$38.91 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for uniQure from 2013 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) C$24.88 M12.9%
2025 C$22.04 M-43.35%
2024 C$38.91 M85.19%
2023 C$21.01 M-85.46%
2022 C$0.14 B-78.36%
2021 C$0.66 B1296.13%
2020 C$47.83 M403.01%
2019 C$9.5 M-38.13%
2018 C$15.37 M-6.72%
2017 C$16.47 M-50.97%
2016 C$33.61 M136.35%
2015 C$14.22 M106.97%
2014 C$6.87 M60.28%
2013 C$4.28 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
C$51.17 B 205,614.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$76.25 B 306,434.30%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
C$45.19 M 81.70%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
C$0.14 B 474.51%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$4.45 B 17,820.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
C$25.78 M 3.66%๐Ÿ‡บ๐Ÿ‡ธ USA